Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci carriers?

Saliba R, Neulier C, Seytre D, Fiacre A, Faibis F, Leduc P, Amara M, Jauréguy F, Carbonnelle E, Zahar JR, Marty L.

J Hosp Infect. 2019 Oct;103(2):115-120. doi: 10.1016/j.jhin.2019.07.004. Epub 2019 Jul 4.

PMID:
31279758
2.

Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.

Macaux L, Ndoye O, Cordel H, Pomares TB, Seytre D, Bouchaud O, Cohen Y, Zahar JR, Carbonnelle E.

Int J Antimicrob Agents. 2018 Sep;52(3):385-389. doi: 10.1016/j.ijantimicag.2018.06.006. Epub 2018 Jun 12.

PMID:
29906564
3.

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V.

Euro Surveill. 2012 Jul 26;17(30). pii: 20229.

4.

Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.

Tod M, Lortholary O, Seytre D, Semaoun R, Uzzan B, Guillevin L, Casassus P, Petitjean O.

Antimicrob Agents Chemother. 1998 Apr;42(4):849-56.

Supplemental Content

Loading ...
Support Center